SOMAIYA MAYUR IAN (Chief Financial Officer) sold 13.5% of their position (5.12K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market sale worth $170.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2026ACC: 0001193125-26-006658
Officer· Chief Financial Officer
Since Dec 2023
+135.38K
Net shares
Net buyer
$170.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
140.50K acquired · 5.12K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−5.12K
Price / share
$33.25
Trade value
$170.17K
% of position
13.5%
1/5/2026
38K→32.88K
Ordinary Shares
Direct
Shares
+25.50K
Price / share
—
Trade value
—
% of position
77.6%
1/7/2026
32.88K→58.38K
Total
Net shares
+20.38K
Net value
-$170.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/5/2026 | S · Sale | −5.12K | $33.25 | $170.17K | 13.5% | 38K | 32.88K |
| Ordinary Shares Direct | 1/7/2026 | A · Award | +25.50K | — | — | 77.6% | 32.88K | 58.38K |
| Total | +20.38K | -$170.17K | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Ordinary Shares
115K shares
Shares
+115K
Strike price
35.45
Held after
115K
Exercisable
—
1/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares115K shares | 1/7/2026 | A · Award | +115K | 35.45 | — | 115K |